Rapid Micro Biosystems (NASDAQ:RPID) Slips on Wider Q2 Loss as Revenue Matches Estimates
RPID Q2 revenue meets estimates at $8.05M, but adjusted EPS loss of -$0.27 misses; shares fall ~3.8% pre-market.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill